LOAN AGREEMENT --------------Loan Agreement • October 18th, 2000 • Integ Incorp • Industrial instruments for measurement, display, and control • Massachusetts
Contract Type FiledOctober 18th, 2000 Company Industry Jurisdiction
AMENDMENT NO. 1 TO RIGHTS AGREEMENTRights Agreement • February 16th, 2000 • Integ Incorp • Industrial instruments for measurement, display, and control
Contract Type FiledFebruary 16th, 2000 Company Industry
Exhibit 10.3 SEPARATION AGREEMENT AND GENERAL RELEASE ---------------------------------------- This Separation Agreement and General Release ("Agreement") is between Katia P. Breslawec ("you") and Integ Incorporated (the "Company"). You have...Separation Agreement • November 5th, 1998 • Integ Incorp • Industrial instruments for measurement, display, and control • Minnesota
Contract Type FiledNovember 5th, 1998 Company Industry Jurisdiction
Exhibit 10.1 INTEG INCORPORATED, INC. EMPLOYMENT AGREEMENT THIS AGREEMENT ("Agreement") is effective as of April __, 1998 by and between Integ Incorporated (the "Company"), a Minnesota corporation, and _____________________ (the "Employee"), a...Employment Agreement • August 14th, 1998 • Integ Incorp • Industrial instruments for measurement, display, and control • Minnesota
Contract Type FiledAugust 14th, 1998 Company Industry Jurisdiction
TABLE OF CONTENTS ----------------- PAGE ---- Section 1. Certain Definitions................................. 1 Section 2. Appointment of Rights Agent......................... 4 Section 3. Issue of Right Certificates......................... 5 Section...Rights Agreement • December 6th, 1996 • Integ Incorp • Industrial instruments for measurement, display, and control • Minnesota
Contract Type FiledDecember 6th, 1996 Company Industry Jurisdiction
Exhibit 10.11 INTEG INCORPORATED NON-INCENTIVE STOCK OPTION AGREEMENT THIS AGREEMENT, effective as of __________, _____ (the "Effective Date"), is entered into by and between Integ Incorporated, a Minnesota corporation (the "Company"), and...Non-Incentive Stock Option Agreement • March 29th, 1999 • Integ Incorp • Industrial instruments for measurement, display, and control
Contract Type FiledMarch 29th, 1999 Company Industry
Exhibit 10.1 SEPARATION AGREEMENT This Separation Agreement (hereinafter "Agreement") is made and entered into by and between Frank A. Solomon (hereinafter "Solomon") and Integ Incorporated (hereinafter "the Company"). WHEREAS, Solomon has been...Separation Agreement • May 14th, 1998 • Integ Incorp • Industrial instruments for measurement, display, and control • Minnesota
Contract Type FiledMay 14th, 1998 Company Industry Jurisdiction
Exhibit 10.2 OPTION AGREEMENT THIS OPTION AGREEMENT (the "Agreement") is made as of April 2, 1999, by and between Amira Medical, a Delaware corporation located at 4742 Scotts Valley Drive, Scotts Valley, CA 95066 ("Amira"), and Integ Incorporated, a...Option Agreement • April 9th, 1999 • Integ Incorp • Industrial instruments for measurement, display, and control • Delaware
Contract Type FiledApril 9th, 1999 Company Industry Jurisdiction
EXHIBIT 10.1 ------------ INTEG INCORPORATED CONSULTING AGREEMENT This Agreement is made effective the 3/rd/ day of April 1997 by and between Integ Incorporated (Integ), a Minnesota corporation, whose principal place of business is 2800 Patton Road,...Consulting Agreement • May 14th, 1997 • Integ Incorp • Industrial instruments for measurement, display, and control • Minnesota
Contract Type FiledMay 14th, 1997 Company Industry Jurisdiction
EXHIBIT 4.1 INTEG INCORPORATED SERIES B PREFERRED STOCK PURCHASE AGREEMENT This Agreement is made and entered into as of the 15th day of February, 2000, by and between Integ Incorporated, a Minnesota corporation (the "Company") and Amira Medical, a...Preferred Stock Purchase Agreement • February 16th, 2000 • Integ Incorp • Industrial instruments for measurement, display, and control • Minnesota
Contract Type FiledFebruary 16th, 2000 Company Industry Jurisdiction
EXHIBIT 10.1 Integ Incorporated Consulting Agreement This Agreement is made effective the 3rd day of April, 2000 by and between Integ Incorporated (Integ), a Minnesota corporation, whose principal place of business is 2800 Patton Road, St. Paul, MN...Integ Incorporated • May 12th, 2000 • Integ Incorp • Industrial instruments for measurement, display, and control • Minnesota
Contract Type FiledMay 12th, 2000 Company Industry Jurisdiction
EXHIBIT 10.1 SUBLEASE AGREEMENT This Sublease Agreement ("Sublease"), made and entered into this 8th day of July, 1999 by and between Integ, Inc., a Minnesota corporation ("Integ"), and Venturi Group, LLC, a Delaware limited liability company...Sublease Agreement • November 12th, 1999 • Integ Incorp • Industrial instruments for measurement, display, and control
Contract Type FiledNovember 12th, 1999 Company Industry
Exhibit 10.1 DEVELOPMENT AND LICENSE AGREEMENT This DEVELOPMENT AND LICENSE AGREEMENT (the "Agreement"), effective as of April 2, 1999 ("Effective Date"), is made by and between Amira Medical, a Delaware corporation, with a principal place of business...Development and License Agreement • April 9th, 1999 • Integ Incorp • Industrial instruments for measurement, display, and control • New York
Contract Type FiledApril 9th, 1999 Company Industry Jurisdiction
EXHIBIT 10.1 ------------ WESTERN TECHNOLOGY INVESTMENT August 7, 1997 Mr. John Brintnall Vice President of Finance & CFO Integ Incorporated 2800 Patton Road St. Paul, MN 55113 Re: Loan Agreement Between Integ (Borrower) and Venture Lending & Leasing,...Integ Incorp • August 13th, 1997 • Industrial instruments for measurement, display, and control
Company FiledAugust 13th, 1997 IndustryThis letter will outline our understanding with respect to any Loan to be funded by Lender after the date of this letter and during the period of Borrower's redesign of their LifeGuide System. Lender will advance 50% against Equipment submitted by Borrower and approved by Lender up to the date when Borrower issues a press release which indicates that its in-house testing of the LifeGuide System has resulted in performance which should allow the Borrower to initiate within 90 days, human clinical trials, the results of which will be used in the Borrower's 510(k) submission to the FDA. Subsequent to the date of the press release, all future Loans will be made in accordance with the Loan Agreement and the Lender will advance the balance of any Loans that were partially funded during the period covered by this letter.